✦ LIBER ✦

Biochemical and pharmacological properties of BW 1370U87 — a novel, selective monoamine oxidase A inhibitor

✍ Scribed by White, H.L; Beek, O; Rigdon, G; Kraemer, G.W; Cooper, B.R

Book ID: 122027090
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 225 KB
Volume: 1
Category: Article
ISSN: 0924-977X
DOI: 10.1016/0924-977X(91)90544-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanism of monoamine oxidase-A inhibit

Mechanism of monoamine oxidase-A inhibition by BW 1370U87

✍ Dr. Helen L. White; Philip W. Scates 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Potentiation of the behavioral effects o

Potentiation of the behavioral effects of 5-hydroxytryptophan by BW 1370U87, a selective monoamine oxidase-A inhibitor

✍ Christopher J. Burchall; Francis E. Soroko; Greg C. Rigdon 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

BW 1370U87, a new monoamine oxidase-A in

BW 1370U87, a new monoamine oxidase-A inhibitor: Effects on biogenic amine neurotransmitter and metabolite levels in rat brain

✍ Stacey A. Jones-Humble; Ron M. Norton; Helen L. White; Barrett R. Cooper 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

Effect of a novel monamine oxidase-a inh

Effect of a novel monamine oxidase-a inhibitor, bw 1370U87, on urinary 3-methoxy-4-hydroxyphenylglycol in normal volunteers

✍ Kevin M. Hedeen; Helen L. White; Barrett R. Cooper; Gary W. Conner; Ronald M. No 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB

Overview of the CNS pharmacology of BW 1

Overview of the CNS pharmacology of BW 1370U87: A chemically novel, reversible, selective MAO-A inhibitor with potential to be a new antidepressant drug

✍ Dr. B. R. Cooper; H. L. White; O. Beek; R. M. Norton; G. C. Rigdon; J. L. Howard 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB

Biochemical and pharmacologic properties

Biochemical and pharmacologic properties of 2614W94, a reversible, competitive inhibitor of monoamine oxidase-A

✍ Helen L. White; Philip W. Scates; Jane C. Harrelson; Thomas E. Johnson; Ron M. N 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

## 2614W94 [3-(1-trifluoromethyl) ethoxyphenoxathiin 10,10-dioxide] is a selective, reversible inhibitor of monoamine oxidase-A with a competitive mechanism of inhibition and a K i value of 1.6 nM with serotonin as substrate. In pretreated rats, the ED 50 value after single oral dosing was 1.7 mg/